Selected research
Industry Research
Taurine and Derivatives Industry Research Report 2026
Market perspective
The global Taurine and Derivatives market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Taurine and Derivatives is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Taurine and Derivatives is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Taurine and Derivatives is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Taurine and Derivatives include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Taurine and Derivatives market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Taurine and Derivatives.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Taurine and Derivatives Market by Company
Taisho Pharmaceutical
Yuanyang Pharmaceutical
Jiangyin Huachang
Yongan Pharmaceutical
Zhejiang NHU Co., Ltd
Grand Pharma
Taurine and Derivatives Segment by Type
Taurine
Taurine Derivatives
Taurine and Derivatives Segment by Application
Beverages
Pet Food
Health Products
Others
Taurine and Derivatives Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taurine and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Taurine and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taurine and Derivatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Taurine and Derivatives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Taurine and Derivatives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Taurine and Derivatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Taurine
- Taurine Derivatives
Applications
- Beverages
- Pet Food
- Health Products
- Others
Companies covered
- Taisho Pharmaceutical
- Yuanyang Pharmaceutical
- Jiangyin Huachang
- Yongan Pharmaceutical
- Zhejiang NHU Co., Ltd
- Grand Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Taurine and Derivatives by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Taurine
- 2.2.3 Taurine Derivatives
- 2.3 Taurine and Derivatives by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Beverages
- 2.3.3 Pet Food
- 2.3.4 Health Products
- 2.3.5 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Taurine and Derivatives Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Taurine and Derivatives Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Taurine and Derivatives Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Taurine and Derivatives Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Taurine and Derivatives Production by Manufacturers (2021-2026)
- 3.2 Global Taurine and Derivatives Production Value by Manufacturers (2021-2026)
- 3.3 Global Taurine and Derivatives Average Price by Manufacturers (2021-2026)
- 3.4 Global Taurine and Derivatives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Taurine and Derivatives Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Taurine and Derivatives Manufacturers, Product Type & Application
- 3.7 Global Taurine and Derivatives Manufacturers Established Date
- 3.8 Global Taurine and Derivatives Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Taisho Pharmaceutical
- 4.1.1 Taisho Pharmaceutical Taurine and Derivatives Company Information
- 4.1.2 Taisho Pharmaceutical Taurine and Derivatives Business Overview
- 4.1.3 Taisho Pharmaceutical Taurine and Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Taisho Pharmaceutical Product Portfolio
- 4.1.5 Taisho Pharmaceutical Recent Developments
- 4.2 Yuanyang Pharmaceutical
- 4.2.1 Yuanyang Pharmaceutical Taurine and Derivatives Company Information
- 4.2.2 Yuanyang Pharmaceutical Taurine and Derivatives Business Overview
- 4.2.3 Yuanyang Pharmaceutical Taurine and Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Yuanyang Pharmaceutical Product Portfolio
- 4.2.5 Yuanyang Pharmaceutical Recent Developments
- 4.3 Jiangyin Huachang
- 4.3.1 Jiangyin Huachang Taurine and Derivatives Company Information
- 4.3.2 Jiangyin Huachang Taurine and Derivatives Business Overview
- 4.3.3 Jiangyin Huachang Taurine and Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Jiangyin Huachang Product Portfolio
- 4.3.5 Jiangyin Huachang Recent Developments
- 4.4 Yongan Pharmaceutical
- 4.4.1 Yongan Pharmaceutical Taurine and Derivatives Company Information
- 4.4.2 Yongan Pharmaceutical Taurine and Derivatives Business Overview
- 4.4.3 Yongan Pharmaceutical Taurine and Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Yongan Pharmaceutical Product Portfolio
- 4.4.5 Yongan Pharmaceutical Recent Developments
- 4.5 Zhejiang NHU Co., Ltd
- 4.5.1 Zhejiang NHU Co., Ltd Taurine and Derivatives Company Information
- 4.5.2 Zhejiang NHU Co., Ltd Taurine and Derivatives Business Overview
- 4.5.3 Zhejiang NHU Co., Ltd Taurine and Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Zhejiang NHU Co., Ltd Product Portfolio
- 4.5.5 Zhejiang NHU Co., Ltd Recent Developments
- 4.6 Grand Pharma
- 4.6.1 Grand Pharma Taurine and Derivatives Company Information
- 4.6.2 Grand Pharma Taurine and Derivatives Business Overview
- 4.6.3 Grand Pharma Taurine and Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Grand Pharma Product Portfolio
- 4.6.5 Grand Pharma Recent Developments
5 Global Taurine and Derivatives Production by Region
- 5.1 Global Taurine and Derivatives Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Taurine and Derivatives Production by Region: 2021-2032
- 5.2.1 Global Taurine and Derivatives Production by Region: 2021-2026
- 5.2.2 Global Taurine and Derivatives Production Forecast by Region (2027-2032)
- 5.3 Global Taurine and Derivatives Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Taurine and Derivatives Production Value by Region: 2021-2032
- 5.4.1 Global Taurine and Derivatives Production Value by Region: 2021-2026
- 5.4.2 Global Taurine and Derivatives Production Value Forecast by Region (2027-2032)
- 5.5 Global Taurine and Derivatives Market Price Analysis by Region (2021-2026)
- 5.6 Global Taurine and Derivatives Production and Value, YOY Growth
- 5.6.1 North America Taurine and Derivatives Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Taurine and Derivatives Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Taurine and Derivatives Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Taurine and Derivatives Production Value Estimates and Forecasts (2021-2032)
6 Global Taurine and Derivatives Consumption by Region
- 6.1 Global Taurine and Derivatives Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Taurine and Derivatives Consumption by Region (2021-2032)
- 6.2.1 Global Taurine and Derivatives Consumption by Region: 2021-2026
- 6.2.2 Global Taurine and Derivatives Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Taurine and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Taurine and Derivatives Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.4 Europe
- 6.4.1 Europe Taurine and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Taurine and Derivatives Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Taurine and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Taurine and Derivatives Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 China Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Taurine and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Taurine and Derivatives Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Taurine and Derivatives Production by Type (2021-2032)
- 7.1.1 Global Taurine and Derivatives Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Taurine and Derivatives Production Market Share by Type (2021-2032)
- 7.2 Global Taurine and Derivatives Production Value by Type (2021-2032)
- 7.2.1 Global Taurine and Derivatives Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Taurine and Derivatives Production Value Market Share by Type (2021-2032)
- 7.3 Global Taurine and Derivatives Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Taurine and Derivatives Production by Application (2021-2032)
- 8.1.1 Global Taurine and Derivatives Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Taurine and Derivatives Production Market Share by Application (2021-2032)
- 8.2 Global Taurine and Derivatives Production Value by Application (2021-2032)
- 8.2.1 Global Taurine and Derivatives Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Taurine and Derivatives Production Value Market Share by Application (2021-2032)
- 8.3 Global Taurine and Derivatives Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Taurine and Derivatives Value Chain Analysis
- 9.1.1 Taurine and Derivatives Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Taurine and Derivatives Production Mode & Process
- 9.2 Taurine and Derivatives Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Taurine and Derivatives Distributors
- 9.2.3 Taurine and Derivatives Customers
10 Global Taurine and Derivatives Analyzing Market Dynamics
- 10.1 Taurine and Derivatives Industry Trends
- 10.2 Taurine and Derivatives Industry Drivers
- 10.3 Taurine and Derivatives Industry Opportunities and Challenges
- 10.4 Taurine and Derivatives Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst